Vivimed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve 31st december 2025 results
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs has informed BSE that its Board of Directors will meet on Friday, 13 February 2026 at Hyderabad. The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. Any other business items may also be taken up during the meeting. This is a routine compliance filing under SEBI Listing Regulations.
This is a standard pre-results intimation with no new information on business performance. Investors should watch for the actual Q3 FY26 numbers, which will be released after the board meeting on 13 February 2026.